Oura Faces Scrutiny Over $16bn Valuation Amid Growth Challenges
The health technology firm must demonstrate substantial growth beyond celebrity endorsements to justify its recent market valuation.
This story has stopped developing; this page is its permanent record. More from that day
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- Oura